In breast cancer research, intrinsic expression of P-gp and BCRP have been associated with poor prognosis, poor response to chemotherapy, amplification of the Human Epidermal Growth Factor Receptor type 2 (HER2) oncogene and hormonal negative status [5,6]. This evidence concerns the gene ERBB2 and breast carcinoma.